Cardiovascular Systems Inc (CSII):企業のM&A・提携動向(医療機器分野)

【英語タイトル】Cardiovascular Systems Inc (CSII) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(GDME2258D)・商品コード:GDME2258D
・発行会社(調査会社):GlobalData
・発行日:2017年2月14日
・ページ数:35
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for treating peripheral and coronary vascular disease. The company offers products such as peripheral orbital atherectomy system,coronary orbital atherectomy system, crowns, and accessories. Its PAD system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. The company markets its products through its network of distributors. CSI is headquartered in Saint Paul, Minnesota, the US.

Cardiovascular Systems Inc (CSII) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cardiovascular Systems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cardiovascular Systems Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cardiovascular Systems Inc, Medical Equipment, Deal Details 10
Partnerships 10
Cardiovascular Systems Enters into Distribution Agreement with Medikit 10
Equity Offering 10
Cardiovascular Systems Completes Public Offering Of Shares For US$101.7 Million 10
Cardiovascular Systems Completes Public Offering Of Shares For US$40.5 Million 12
Cardiovascular Systems Completes Public Offering Of Common Stock For US$16 Million 13
Cardiovascular Systems Announces Private Placement Of Shares For US$1.5 Million Upon Exercise Of Warrants 14
Cardiovascular Systems Inc – Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Financial Announcements 19
Jan 25, 2017: Cardiovascular Systems Reports Fiscal 2017 Second-Quarter Financial Results 19
Oct 26, 2016: Cardiovascular Systems Reports Fiscal 2017 First-Quarter Financial Results 21
Aug 03, 2016: Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial Results 23
May 04, 2016: Cardiovascular Systems Reports Fiscal 2016 Third-Quarter Financial Results 25
Mar 31, 2016: Cardiovascular Systems Reports Stronger Than Expected Preliminary Fiscal Third-Quarter Revenue 27
Jan 21, 2016: Cardiovascular Systems Reports Fiscal 2016 Second-Quarter Financial Results 28
Corporate Communications 30
Aug 16, 2016: Cardiovascular Systems Names Scott Ward as CEO 30
Feb 29, 2016: Cardiovascular Systems CEO David L. Martin Steps Down to Focus on His Cancer Treatment 31
Legal and Regulatory 32
Feb 16, 2016: Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Cardiovascular Systems 32
Product News 33
Feb 22, 2016: Cardiovascular Systems Releases 30-Day Results from COAST IDE Study in Late-Breaking Presentation at 2016 Cardiovascular Research Technologies Conference 33
Clinical Trials 34
Feb 22, 2016: Cardiovascular Systems Releases 30-Day Results from COAST IDE Study in Late-Breaking Presentation at 2016 Cardiovascular Research Technologies Conference 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Cardiovascular Systems Inc, Medical Equipment, Key Facts, 2016 1
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cardiovascular Systems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cardiovascular Systems Inc, Deals By Market, 2011 to YTD 2017 8
Cardiovascular Systems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cardiovascular Systems Enters into Distribution Agreement with Medikit 10
Cardiovascular Systems Completes Public Offering Of Shares For US$101.7 Million 10
Cardiovascular Systems Completes Public Offering Of Shares For US$40.5 Million 12
Cardiovascular Systems Completes Public Offering Of Common Stock For US$16 Million 13
Cardiovascular Systems Announces Private Placement Of Shares For US$1.5 Million Upon Exercise Of Warrants 14
Cardiovascular Systems Inc, Key Competitors 16
Cardiovascular Systems Inc, Key Employees 17

List of Figures
Cardiovascular Systems Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Cardiovascular Systems Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Cardiovascular Systems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cardiovascular Systems Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Cardiovascular Systems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cardiovascular Systems Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

★調査レポート[Cardiovascular Systems Inc (CSII):企業のM&A・提携動向(医療機器分野)] (コード:GDME2258D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Cardiovascular Systems Inc (CSII):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆